Merus Labs
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Merus Labs and buy or sell other stocks, ETFs, and their options commission-free!About MSLI
Merus Labs International, Inc. wass a pharmaceutical company. It was engaged in the acquisition of mature prescription and over the counter pharmaceutical products and licensing in of novel hospital products.
CEOPaul Pay
CEOPaul Pay
Employees—
Employees—
HeadquartersVancouver, British Columbia
HeadquartersVancouver, British Columbia
Founded2011
Founded2011
Employees—
Employees—
MSLI Key Statistics
Market cap152.56M
Market cap152.56M
Price-Earnings ratio-16.99
Price-Earnings ratio-16.99
Dividend yield—
Dividend yield—
Average volume3.71K
Average volume3.71K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$1.33
52 Week high$1.33
52 Week low$0.7005
52 Week low$0.7005
Stock Snapshot
The current Merus Labs(MSLI) stock price is $1.30, with a market capitalization of 152.56M. The stock trades at a price-to-earnings (P/E) ratio of -16.99.
On 2025-12-14, Merus Labs(MSLI) stock opened at —, reached a high of —, and a low of —.
The Merus Labs(MSLI)'s current trading volume is 0, compared to an average daily volume of 3.71K.
In the last year, Merus Labs(MSLI) shares hit a 52-week high of $1.33 and a 52-week low of $0.70.
In the last year, Merus Labs(MSLI) shares hit a 52-week high of $1.33 and a 52-week low of $0.70.